Benzinga | Sep 10, 2021 09:41AM EDT

Sangamo Therapeutics 'Long-Term Follow-up of Subjects Who Were Treated With ST-920' Posted To ClinicalTrials.Gov; Study Enrolling By Invitation

https://clinicaltrials.gov/ct2/show/NCT05039866